ROYAL BANK OF CANADA - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 3 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 7.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,160,000
+12788.9%
1,185,000
+11750.0%
0.00%
Q4 2022$9,00010,0000.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Cohanzick Management, LLC 25,112,000$25,557,98222.10%
Westchester Capital Management, LLC 8,267,000$8,308,5360.24%
MACQUARIE GROUP LTD 5,359,000$5,386,0000.01%
View complete list of PARATEK PHARMACEUTICALS INC shareholders